These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 315906)

  • 21. Central nervous system and blood lymphocytes in experimental allergic encephalomyelitis.
    Lublin FD; Tippett DL; Maurer PH
    J Clin Lab Immunol; 1983 Mar; 10(3):139-42. PubMed ID: 6842578
    [No Abstract]   [Full Text] [Related]  

  • 22. The response of the nude (athymic) rat to actively induced and adoptively transferred experimental allergic encephalomyelitis.
    Hinrichs DJ; Humphres RC
    J Immunol; 1983 Jul; 131(1):4-5. PubMed ID: 6190918
    [No Abstract]   [Full Text] [Related]  

  • 23. Experimental allergic encephalomyelitis: activation of suppressor T lymphocytes by a modified sequence of the T effector determinant.
    Hashim GA
    J Immunol; 1981 Feb; 126(2):419-23. PubMed ID: 6161172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concanavalin A inhibits the development of experimental allergic encephalomyelitis in guinea pigs.
    Kuroda Y; Mori R; Aoki T
    Int Arch Allergy Appl Immunol; 1980; 61(3):308-20. PubMed ID: 6965490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mechanism of suppression of colchicine in experimental allergic encephalomyelitis].
    Tateyama M
    Hokkaido Igaku Zasshi; 1988 Jan; 63(1):72-9. PubMed ID: 2452125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Various immunological aspects of demyelinations. I. Information on the mechanisms of induction and inhibition of experimental allergic encephalitis].
    Vymazal J; Krásenská-Dlabacová J
    Cesk Neurol Neurochir; 1974 Jul; 37(4):235-9. PubMed ID: 4846372
    [No Abstract]   [Full Text] [Related]  

  • 27. Experimental allergic encephalomyelitis: effect of neonatal exposure to neuroantigen or neuroantigen immune cells on subsequent reactivity as adults.
    Willenborg DO; Danta G
    Clin Exp Neurol; 1985; 21():226-31. PubMed ID: 3843222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transformation of lymphocytes from monkeys with experimental allergic encephalomyelitis.
    Chaparas SD; Clark RG; Kies MW; Hedrick SR
    Res Commun Chem Pathol Pharmacol; 1970 Sep; 1(5):637-52. PubMed ID: 5002788
    [No Abstract]   [Full Text] [Related]  

  • 29. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells.
    Hilliard BA; Kamoun M; Ventura E; Rostami A
    Exp Mol Pathol; 2000 Feb; 68(1):29-37. PubMed ID: 10640452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro stimuli required for enhanced transfer of experimental allergic encephalomyelitis with myelin basic protein sensitized guinea pig peritoneal exudate cells.
    Fujii T; Driscoll BF
    Prog Clin Biol Res; 1984; 146():299-305. PubMed ID: 6201902
    [No Abstract]   [Full Text] [Related]  

  • 31. [Isolation and identification of antigen-specific T-cell-receptors (author's transl)].
    Bartmann P; Brendel W
    J Clin Chem Clin Biochem; 1980 Jan; 18(1):1-5. PubMed ID: 6153698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proceedings: Immunogenetic aspects of demyelinating disease.
    Arnason BG; Chelmicka-Szorc E
    Neurology; 1975 May; 25(5):489. PubMed ID: 1079582
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experimental allergic encephalomyelitis antigen (author's transl)].
    Nagai Y; Nakano K
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(10):794-9. PubMed ID: 4140545
    [No Abstract]   [Full Text] [Related]  

  • 34. The generation of the relapse in chronic relapsing experimental allergic encephalomyelitis and multiple sclerosis--parallels and differences.
    Suckling AJ; Kirby JA; Wilson NR; Rumsby MG
    Prog Clin Biol Res; 1984; 146():7-12. PubMed ID: 6609376
    [No Abstract]   [Full Text] [Related]  

  • 35. Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide.
    Teitelbaum D; Meshorer A; Hirshfeld T; Arnon R; Sela M
    Eur J Immunol; 1971 Aug; 1(4):242-8. PubMed ID: 5157960
    [No Abstract]   [Full Text] [Related]  

  • 36. [Electrophoretic mobility of lymph node cells in experimental allergic encephalomyelitis].
    Jenssen HL; Köhler H; Gundlach HJ; Günther J; Eckert R
    Acta Biol Med Ger; 1974; 32(1):113-9. PubMed ID: 4547024
    [No Abstract]   [Full Text] [Related]  

  • 37. Activation of peripheral lymphocytes in the course of experimental allergic encephalomyelitis in the guinea-pig.
    Pekárek J; Vepreková A; Doutlík S
    Z Immunitatsforsch Exp Klin Immunol; 1972 Mar; 143(2):139-46. PubMed ID: 4143076
    [No Abstract]   [Full Text] [Related]  

  • 38. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes.
    Lider O; Santos LM; Lee CS; Higgins PJ; Weiner HL
    J Immunol; 1989 Feb; 142(3):748-52. PubMed ID: 2464023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction.
    Hinrichs DJ; Roberts CM; Waxman FJ
    J Immunol; 1981 May; 126(5):1857-62. PubMed ID: 6163820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Passive transfer studies in experimental allergic encephalomyelitis.
    Rauch HC; Griffin J
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:387-400. PubMed ID: 5373036
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.